nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—CXCL8—atherosclerosis	0.241	0.644	CbGaD
Ketoprofen—PTGS2—atherosclerosis	0.0703	0.188	CbGaD
Ketoprofen—ALB—atherosclerosis	0.0626	0.167	CbGaD
Ketoprofen—ABCC4—Rosuvastatin—atherosclerosis	0.0517	0.118	CbGbCtD
Ketoprofen—SLC22A11—Pravastatin—atherosclerosis	0.0505	0.115	CbGbCtD
Ketoprofen—SLC22A7—Pravastatin—atherosclerosis	0.0481	0.11	CbGbCtD
Ketoprofen—SLCO1A2—Rosuvastatin—atherosclerosis	0.0371	0.0847	CbGbCtD
Ketoprofen—SLCO1A2—Simvastatin—atherosclerosis	0.0345	0.0787	CbGbCtD
Ketoprofen—SLCO1A2—Lovastatin—atherosclerosis	0.0337	0.0771	CbGbCtD
Ketoprofen—SLCO1A2—Pravastatin—atherosclerosis	0.0337	0.0771	CbGbCtD
Ketoprofen—SLC22A8—Pravastatin—atherosclerosis	0.0294	0.0671	CbGbCtD
Ketoprofen—SLC22A6—Pravastatin—atherosclerosis	0.0205	0.0467	CbGbCtD
Ketoprofen—ALB—Rosuvastatin—atherosclerosis	0.0192	0.0438	CbGbCtD
Ketoprofen—CYP2C8—Simvastatin—atherosclerosis	0.0138	0.0314	CbGbCtD
Ketoprofen—CYP2C8—Pravastatin—atherosclerosis	0.0135	0.0308	CbGbCtD
Ketoprofen—CYP2C8—Lovastatin—atherosclerosis	0.0135	0.0308	CbGbCtD
Ketoprofen—CYP2C9—Rosuvastatin—atherosclerosis	0.0103	0.0236	CbGbCtD
Ketoprofen—CYP2C9—Simvastatin—atherosclerosis	0.0096	0.0219	CbGbCtD
Ketoprofen—CYP2C9—Pravastatin—atherosclerosis	0.0094	0.0215	CbGbCtD
Ketoprofen—CYP2C9—Lovastatin—atherosclerosis	0.0094	0.0215	CbGbCtD
Ketoprofen—CXCR1—adipose tissue—atherosclerosis	0.00132	0.15	CbGeAlD
Ketoprofen—PTGS2—leg—atherosclerosis	0.00074	0.0838	CbGeAlD
Ketoprofen—PTGS2—hindlimb—atherosclerosis	0.000661	0.0749	CbGeAlD
Ketoprofen—PTGS2—appendage—atherosclerosis	0.000567	0.0642	CbGeAlD
Ketoprofen—CXCL8—adipose tissue—atherosclerosis	0.000468	0.053	CbGeAlD
Ketoprofen—PTGS1—artery—atherosclerosis	0.000424	0.048	CbGeAlD
Ketoprofen—PTGS2—artery—atherosclerosis	0.000405	0.0459	CbGeAlD
Ketoprofen—PTGS1—endothelium—atherosclerosis	0.000358	0.0406	CbGeAlD
Ketoprofen—PTGS2—endothelium—atherosclerosis	0.000342	0.0388	CbGeAlD
Ketoprofen—PTGS1—blood vessel—atherosclerosis	0.00033	0.0374	CbGeAlD
Ketoprofen—CXCL8—liver—atherosclerosis	0.000328	0.0372	CbGeAlD
Ketoprofen—PTGS2—blood vessel—atherosclerosis	0.000316	0.0358	CbGeAlD
Ketoprofen—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000303	0.00342	CcSEcCtD
Ketoprofen—Stomatitis—Niacin—atherosclerosis	0.000302	0.00341	CcSEcCtD
Ketoprofen—Jaundice—Niacin—atherosclerosis	0.000302	0.00341	CcSEcCtD
Ketoprofen—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000301	0.0034	CcSEcCtD
Ketoprofen—Flushing—Lovastatin—atherosclerosis	0.000301	0.0034	CcSEcCtD
Ketoprofen—Erythema multiforme—Ezetimibe—atherosclerosis	0.000301	0.00339	CcSEcCtD
Ketoprofen—Myocardial infarction—Pravastatin—atherosclerosis	0.000299	0.00338	CcSEcCtD
Ketoprofen—Jaundice—Pravastatin—atherosclerosis	0.000298	0.00336	CcSEcCtD
Ketoprofen—Sweating—Niacin—atherosclerosis	0.000297	0.00336	CcSEcCtD
Ketoprofen—Flushing—Ezetimibe—atherosclerosis	0.000295	0.00333	CcSEcCtD
Ketoprofen—Chills—Lovastatin—atherosclerosis	0.000291	0.00328	CcSEcCtD
Ketoprofen—Erythema multiforme—Simvastatin—atherosclerosis	0.000287	0.00324	CcSEcCtD
Ketoprofen—Alopecia—Lovastatin—atherosclerosis	0.000286	0.00323	CcSEcCtD
Ketoprofen—Myalgia—Rosuvastatin—atherosclerosis	0.000283	0.0032	CcSEcCtD
Ketoprofen—Flushing—Simvastatin—atherosclerosis	0.000281	0.00318	CcSEcCtD
Ketoprofen—Alopecia—Ezetimibe—atherosclerosis	0.000281	0.00317	CcSEcCtD
Ketoprofen—Rhinitis—Niacin—atherosclerosis	0.000279	0.00315	CcSEcCtD
Ketoprofen—Hepatitis—Niacin—atherosclerosis	0.000278	0.00314	CcSEcCtD
Ketoprofen—Flatulence—Lovastatin—atherosclerosis	0.000278	0.00314	CcSEcCtD
Ketoprofen—Erythema—Ezetimibe—atherosclerosis	0.000277	0.00312	CcSEcCtD
Ketoprofen—Dysgeusia—Lovastatin—atherosclerosis	0.000276	0.00312	CcSEcCtD
Ketoprofen—Rhinitis—Pravastatin—atherosclerosis	0.000275	0.0031	CcSEcCtD
Ketoprofen—Hepatitis—Pravastatin—atherosclerosis	0.000274	0.00309	CcSEcCtD
Ketoprofen—Confusional state—Rosuvastatin—atherosclerosis	0.000274	0.00309	CcSEcCtD
Ketoprofen—Flatulence—Ezetimibe—atherosclerosis	0.000273	0.00308	CcSEcCtD
Ketoprofen—SLC22A11—liver—atherosclerosis	0.000272	0.0308	CbGeAlD
Ketoprofen—Pharyngitis—Pravastatin—atherosclerosis	0.000272	0.00307	CcSEcCtD
Ketoprofen—Chills—Simvastatin—atherosclerosis	0.000272	0.00307	CcSEcCtD
Ketoprofen—Infection—Rosuvastatin—atherosclerosis	0.00027	0.00305	CcSEcCtD
Ketoprofen—Visual impairment—Niacin—atherosclerosis	0.000268	0.00303	CcSEcCtD
Ketoprofen—Alopecia—Simvastatin—atherosclerosis	0.000268	0.00302	CcSEcCtD
Ketoprofen—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000266	0.003	CcSEcCtD
Ketoprofen—SLC22A7—liver—atherosclerosis	0.000266	0.0301	CbGeAlD
Ketoprofen—Visual impairment—Pravastatin—atherosclerosis	0.000264	0.00298	CcSEcCtD
Ketoprofen—Erythema—Simvastatin—atherosclerosis	0.000264	0.00298	CcSEcCtD
Ketoprofen—Ill-defined disorder—Lovastatin—atherosclerosis	0.000262	0.00296	CcSEcCtD
Ketoprofen—Flatulence—Simvastatin—atherosclerosis	0.00026	0.00294	CcSEcCtD
Ketoprofen—Tinnitus—Niacin—atherosclerosis	0.00026	0.00293	CcSEcCtD
Ketoprofen—Erythema multiforme—Pravastatin—atherosclerosis	0.000259	0.00293	CcSEcCtD
Ketoprofen—Dysgeusia—Simvastatin—atherosclerosis	0.000258	0.00292	CcSEcCtD
Ketoprofen—Flushing—Niacin—atherosclerosis	0.000258	0.00292	CcSEcCtD
Ketoprofen—Angioedema—Lovastatin—atherosclerosis	0.000258	0.00291	CcSEcCtD
Ketoprofen—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000257	0.0029	CcSEcCtD
Ketoprofen—Anaemia—Ezetimibe—atherosclerosis	0.000256	0.00289	CcSEcCtD
Ketoprofen—Tinnitus—Pravastatin—atherosclerosis	0.000256	0.00288	CcSEcCtD
Ketoprofen—Malaise—Lovastatin—atherosclerosis	0.000254	0.00287	CcSEcCtD
Ketoprofen—Flushing—Pravastatin—atherosclerosis	0.000254	0.00287	CcSEcCtD
Ketoprofen—Vertigo—Lovastatin—atherosclerosis	0.000253	0.00286	CcSEcCtD
Ketoprofen—Angioedema—Ezetimibe—atherosclerosis	0.000253	0.00285	CcSEcCtD
Ketoprofen—Chills—Niacin—atherosclerosis	0.00025	0.00282	CcSEcCtD
Ketoprofen—Malaise—Ezetimibe—atherosclerosis	0.00025	0.00282	CcSEcCtD
Ketoprofen—Arrhythmia—Niacin—atherosclerosis	0.000249	0.00281	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000248	0.00279	CcSEcCtD
Ketoprofen—Alopecia—Niacin—atherosclerosis	0.000246	0.00278	CcSEcCtD
Ketoprofen—Chills—Pravastatin—atherosclerosis	0.000246	0.00278	CcSEcCtD
Ketoprofen—Insomnia—Rosuvastatin—atherosclerosis	0.000246	0.00277	CcSEcCtD
Ketoprofen—Ill-defined disorder—Simvastatin—atherosclerosis	0.000245	0.00276	CcSEcCtD
Ketoprofen—Arrhythmia—Pravastatin—atherosclerosis	0.000245	0.00276	CcSEcCtD
Ketoprofen—Palpitations—Ezetimibe—atherosclerosis	0.000245	0.00276	CcSEcCtD
Ketoprofen—Paraesthesia—Rosuvastatin—atherosclerosis	0.000244	0.00275	CcSEcCtD
Ketoprofen—Anaemia—Simvastatin—atherosclerosis	0.000244	0.00275	CcSEcCtD
Ketoprofen—Erythema—Niacin—atherosclerosis	0.000242	0.00274	CcSEcCtD
Ketoprofen—Alopecia—Pravastatin—atherosclerosis	0.000242	0.00273	CcSEcCtD
Ketoprofen—Angioedema—Simvastatin—atherosclerosis	0.000241	0.00272	CcSEcCtD
Ketoprofen—Myalgia—Lovastatin—atherosclerosis	0.00024	0.00271	CcSEcCtD
Ketoprofen—Anxiety—Lovastatin—atherosclerosis	0.000239	0.0027	CcSEcCtD
Ketoprofen—Dyspepsia—Rosuvastatin—atherosclerosis	0.000239	0.0027	CcSEcCtD
Ketoprofen—Hypertension—Ezetimibe—atherosclerosis	0.000239	0.0027	CcSEcCtD
Ketoprofen—Flatulence—Niacin—atherosclerosis	0.000239	0.0027	CcSEcCtD
Ketoprofen—Malaise—Simvastatin—atherosclerosis	0.000238	0.00269	CcSEcCtD
Ketoprofen—Tension—Niacin—atherosclerosis	0.000238	0.00268	CcSEcCtD
Ketoprofen—Discomfort—Lovastatin—atherosclerosis	0.000237	0.00268	CcSEcCtD
Ketoprofen—Vertigo—Simvastatin—atherosclerosis	0.000237	0.00268	CcSEcCtD
Ketoprofen—Myalgia—Ezetimibe—atherosclerosis	0.000236	0.00266	CcSEcCtD
Ketoprofen—Nervousness—Niacin—atherosclerosis	0.000235	0.00266	CcSEcCtD
Ketoprofen—Flatulence—Pravastatin—atherosclerosis	0.000235	0.00265	CcSEcCtD
Ketoprofen—Dry mouth—Lovastatin—atherosclerosis	0.000235	0.00265	CcSEcCtD
Ketoprofen—Tension—Pravastatin—atherosclerosis	0.000234	0.00264	CcSEcCtD
Ketoprofen—Dysgeusia—Pravastatin—atherosclerosis	0.000234	0.00264	CcSEcCtD
Ketoprofen—Discomfort—Ezetimibe—atherosclerosis	0.000233	0.00263	CcSEcCtD
Ketoprofen—Constipation—Rosuvastatin—atherosclerosis	0.000232	0.00262	CcSEcCtD
Ketoprofen—Confusional state—Lovastatin—atherosclerosis	0.000232	0.00262	CcSEcCtD
Ketoprofen—Nervousness—Pravastatin—atherosclerosis	0.000232	0.00262	CcSEcCtD
Ketoprofen—Dry mouth—Ezetimibe—atherosclerosis	0.00023	0.0026	CcSEcCtD
Ketoprofen—Anaphylactic shock—Lovastatin—atherosclerosis	0.00023	0.0026	CcSEcCtD
Ketoprofen—Infection—Lovastatin—atherosclerosis	0.000229	0.00258	CcSEcCtD
Ketoprofen—Confusional state—Ezetimibe—atherosclerosis	0.000228	0.00257	CcSEcCtD
Ketoprofen—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000226	0.00255	CcSEcCtD
Ketoprofen—Thrombocytopenia—Lovastatin—atherosclerosis	0.000225	0.00255	CcSEcCtD
Ketoprofen—Myalgia—Simvastatin—atherosclerosis	0.000225	0.00254	CcSEcCtD
Ketoprofen—Infection—Ezetimibe—atherosclerosis	0.000224	0.00253	CcSEcCtD
Ketoprofen—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000224	0.00253	CcSEcCtD
Ketoprofen—Anxiety—Simvastatin—atherosclerosis	0.000224	0.00253	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000222	0.00251	CcSEcCtD
Ketoprofen—Discomfort—Simvastatin—atherosclerosis	0.000222	0.00251	CcSEcCtD
Ketoprofen—Angioedema—Niacin—atherosclerosis	0.000221	0.0025	CcSEcCtD
Ketoprofen—Ill-defined disorder—Pravastatin—atherosclerosis	0.000221	0.0025	CcSEcCtD
Ketoprofen—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000221	0.0025	CcSEcCtD
Ketoprofen—ABCC4—adipose tissue—atherosclerosis	0.000221	0.025	CbGeAlD
Ketoprofen—Anaemia—Pravastatin—atherosclerosis	0.000221	0.00249	CcSEcCtD
Ketoprofen—Anorexia—Lovastatin—atherosclerosis	0.000219	0.00248	CcSEcCtD
Ketoprofen—Angioedema—Pravastatin—atherosclerosis	0.000218	0.00246	CcSEcCtD
Ketoprofen—Vertigo—Niacin—atherosclerosis	0.000218	0.00246	CcSEcCtD
Ketoprofen—Confusional state—Simvastatin—atherosclerosis	0.000217	0.00245	CcSEcCtD
Ketoprofen—Urticaria—Rosuvastatin—atherosclerosis	0.000216	0.00244	CcSEcCtD
Ketoprofen—Oedema—Simvastatin—atherosclerosis	0.000215	0.00243	CcSEcCtD
Ketoprofen—Anaphylactic shock—Simvastatin—atherosclerosis	0.000215	0.00243	CcSEcCtD
Ketoprofen—Malaise—Pravastatin—atherosclerosis	0.000215	0.00243	CcSEcCtD
Ketoprofen—Abdominal pain—Rosuvastatin—atherosclerosis	0.000215	0.00242	CcSEcCtD
Ketoprofen—Vertigo—Pravastatin—atherosclerosis	0.000214	0.00242	CcSEcCtD
Ketoprofen—Palpitations—Niacin—atherosclerosis	0.000214	0.00242	CcSEcCtD
Ketoprofen—Infection—Simvastatin—atherosclerosis	0.000214	0.00242	CcSEcCtD
Ketoprofen—Thrombocytopenia—Simvastatin—atherosclerosis	0.000211	0.00238	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00021	0.00237	CcSEcCtD
Ketoprofen—Insomnia—Lovastatin—atherosclerosis	0.000208	0.00235	CcSEcCtD
Ketoprofen—Paraesthesia—Lovastatin—atherosclerosis	0.000207	0.00233	CcSEcCtD
Ketoprofen—Myalgia—Niacin—atherosclerosis	0.000206	0.00233	CcSEcCtD
Ketoprofen—Hypertension—Pravastatin—atherosclerosis	0.000206	0.00233	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000206	0.00232	CcSEcCtD
Ketoprofen—Anorexia—Simvastatin—atherosclerosis	0.000205	0.00232	CcSEcCtD
Ketoprofen—Dyspnoea—Lovastatin—atherosclerosis	0.000205	0.00232	CcSEcCtD
Ketoprofen—Insomnia—Ezetimibe—atherosclerosis	0.000204	0.00231	CcSEcCtD
Ketoprofen—Myalgia—Pravastatin—atherosclerosis	0.000203	0.00229	CcSEcCtD
Ketoprofen—Paraesthesia—Ezetimibe—atherosclerosis	0.000203	0.00229	CcSEcCtD
Ketoprofen—Dyspepsia—Lovastatin—atherosclerosis	0.000203	0.00229	CcSEcCtD
Ketoprofen—Anxiety—Pravastatin—atherosclerosis	0.000202	0.00229	CcSEcCtD
Ketoprofen—Dry mouth—Niacin—atherosclerosis	0.000202	0.00228	CcSEcCtD
Ketoprofen—Dyspnoea—Ezetimibe—atherosclerosis	0.000201	0.00227	CcSEcCtD
Ketoprofen—Discomfort—Pravastatin—atherosclerosis	0.000201	0.00227	CcSEcCtD
Ketoprofen—Hypersensitivity—Rosuvastatin—atherosclerosis	0.0002	0.00226	CcSEcCtD
Ketoprofen—Decreased appetite—Lovastatin—atherosclerosis	0.0002	0.00226	CcSEcCtD
Ketoprofen—Carprofen—PTGS2—atherosclerosis	0.0002	0.0845	CrCbGaD
Ketoprofen—Ketorolac—PTGS2—atherosclerosis	0.0002	0.0845	CrCbGaD
Ketoprofen—Dyspepsia—Ezetimibe—atherosclerosis	0.000199	0.00224	CcSEcCtD
Ketoprofen—Fatigue—Lovastatin—atherosclerosis	0.000199	0.00224	CcSEcCtD
Ketoprofen—Oedema—Niacin—atherosclerosis	0.000198	0.00223	CcSEcCtD
Ketoprofen—Anaphylactic shock—Niacin—atherosclerosis	0.000198	0.00223	CcSEcCtD
Ketoprofen—Constipation—Lovastatin—atherosclerosis	0.000197	0.00222	CcSEcCtD
Ketoprofen—Confusional state—Pravastatin—atherosclerosis	0.000196	0.00222	CcSEcCtD
Ketoprofen—Decreased appetite—Ezetimibe—atherosclerosis	0.000196	0.00222	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000196	0.00222	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000195	0.0022	CcSEcCtD
Ketoprofen—Asthenia—Rosuvastatin—atherosclerosis	0.000195	0.0022	CcSEcCtD
Ketoprofen—Insomnia—Simvastatin—atherosclerosis	0.000195	0.0022	CcSEcCtD
Ketoprofen—Oedema—Pravastatin—atherosclerosis	0.000195	0.0022	CcSEcCtD
Ketoprofen—Anaphylactic shock—Pravastatin—atherosclerosis	0.000195	0.0022	CcSEcCtD
Ketoprofen—Fatigue—Ezetimibe—atherosclerosis	0.000195	0.0022	CcSEcCtD
Ketoprofen—Shock—Niacin—atherosclerosis	0.000195	0.0022	CcSEcCtD
Ketoprofen—Infection—Pravastatin—atherosclerosis	0.000193	0.00218	CcSEcCtD
Ketoprofen—Paraesthesia—Simvastatin—atherosclerosis	0.000193	0.00218	CcSEcCtD
Ketoprofen—Constipation—Ezetimibe—atherosclerosis	0.000193	0.00218	CcSEcCtD
Ketoprofen—Tachycardia—Niacin—atherosclerosis	0.000193	0.00218	CcSEcCtD
Ketoprofen—Pruritus—Rosuvastatin—atherosclerosis	0.000192	0.00217	CcSEcCtD
Ketoprofen—Dyspnoea—Simvastatin—atherosclerosis	0.000192	0.00217	CcSEcCtD
Ketoprofen—Bromfenac—PTGS2—atherosclerosis	0.000192	0.081	CrCbGaD
Ketoprofen—Hyperhidrosis—Niacin—atherosclerosis	0.000191	0.00216	CcSEcCtD
Ketoprofen—Thrombocytopenia—Pravastatin—atherosclerosis	0.000191	0.00215	CcSEcCtD
Ketoprofen—Feeling abnormal—Lovastatin—atherosclerosis	0.00019	0.00214	CcSEcCtD
Ketoprofen—Dyspepsia—Simvastatin—atherosclerosis	0.00019	0.00214	CcSEcCtD
Ketoprofen—Anorexia—Niacin—atherosclerosis	0.000189	0.00213	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000188	0.00213	CcSEcCtD
Ketoprofen—Hyperhidrosis—Pravastatin—atherosclerosis	0.000188	0.00212	CcSEcCtD
Ketoprofen—Decreased appetite—Simvastatin—atherosclerosis	0.000187	0.00211	CcSEcCtD
Ketoprofen—Feeling abnormal—Ezetimibe—atherosclerosis	0.000186	0.0021	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000186	0.0021	CcSEcCtD
Ketoprofen—Diarrhoea—Rosuvastatin—atherosclerosis	0.000186	0.0021	CcSEcCtD
Ketoprofen—Fatigue—Simvastatin—atherosclerosis	0.000186	0.0021	CcSEcCtD
Ketoprofen—Anorexia—Pravastatin—atherosclerosis	0.000186	0.0021	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000185	0.00208	CcSEcCtD
Ketoprofen—Constipation—Simvastatin—atherosclerosis	0.000184	0.00208	CcSEcCtD
Ketoprofen—Urticaria—Lovastatin—atherosclerosis	0.000183	0.00206	CcSEcCtD
Ketoprofen—Abdominal pain—Lovastatin—atherosclerosis	0.000182	0.00205	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00018	0.00203	CcSEcCtD
Ketoprofen—Dizziness—Rosuvastatin—atherosclerosis	0.00018	0.00203	CcSEcCtD
Ketoprofen—Urticaria—Ezetimibe—atherosclerosis	0.000179	0.00203	CcSEcCtD
Ketoprofen—Insomnia—Niacin—atherosclerosis	0.000179	0.00202	CcSEcCtD
Ketoprofen—Abdominal pain—Ezetimibe—atherosclerosis	0.000179	0.00202	CcSEcCtD
Ketoprofen—Paraesthesia—Niacin—atherosclerosis	0.000178	0.002	CcSEcCtD
Ketoprofen—Feeling abnormal—Simvastatin—atherosclerosis	0.000177	0.002	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000177	0.002	CcSEcCtD
Ketoprofen—Dyspnoea—Niacin—atherosclerosis	0.000176	0.00199	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000176	0.00199	CcSEcCtD
Ketoprofen—Insomnia—Pravastatin—atherosclerosis	0.000176	0.00199	CcSEcCtD
Ketoprofen—Somnolence—Niacin—atherosclerosis	0.000176	0.00198	CcSEcCtD
Ketoprofen—Paraesthesia—Pravastatin—atherosclerosis	0.000175	0.00197	CcSEcCtD
Ketoprofen—Dyspepsia—Niacin—atherosclerosis	0.000174	0.00197	CcSEcCtD
Ketoprofen—Dyspnoea—Pravastatin—atherosclerosis	0.000174	0.00196	CcSEcCtD
Ketoprofen—Decreased appetite—Niacin—atherosclerosis	0.000172	0.00194	CcSEcCtD
Ketoprofen—Dyspepsia—Pravastatin—atherosclerosis	0.000171	0.00193	CcSEcCtD
Ketoprofen—Rash—Rosuvastatin—atherosclerosis	0.000171	0.00193	CcSEcCtD
Ketoprofen—Dermatitis—Rosuvastatin—atherosclerosis	0.000171	0.00193	CcSEcCtD
Ketoprofen—Urticaria—Simvastatin—atherosclerosis	0.000171	0.00193	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Niacin—atherosclerosis	0.000171	0.00193	CcSEcCtD
Ketoprofen—Abdominal pain—Simvastatin—atherosclerosis	0.00017	0.00192	CcSEcCtD
Ketoprofen—Headache—Rosuvastatin—atherosclerosis	0.00017	0.00192	CcSEcCtD
Ketoprofen—Hypersensitivity—Lovastatin—atherosclerosis	0.00017	0.00192	CcSEcCtD
Ketoprofen—PTGS1—connective tissue—atherosclerosis	0.000169	0.0192	CbGeAlD
Ketoprofen—Decreased appetite—Pravastatin—atherosclerosis	0.000169	0.00191	CcSEcCtD
Ketoprofen—Fatigue—Pravastatin—atherosclerosis	0.000168	0.0019	CcSEcCtD
Ketoprofen—Constipation—Pravastatin—atherosclerosis	0.000167	0.00188	CcSEcCtD
Ketoprofen—Hypersensitivity—Ezetimibe—atherosclerosis	0.000166	0.00188	CcSEcCtD
Ketoprofen—Asthenia—Lovastatin—atherosclerosis	0.000165	0.00186	CcSEcCtD
Ketoprofen—Pruritus—Lovastatin—atherosclerosis	0.000163	0.00184	CcSEcCtD
Ketoprofen—Tiaprofenic acid—PTGS2—atherosclerosis	0.000163	0.0689	CrCbGaD
Ketoprofen—Asthenia—Ezetimibe—atherosclerosis	0.000162	0.00183	CcSEcCtD
Ketoprofen—PTGS2—connective tissue—atherosclerosis	0.000162	0.0183	CbGeAlD
Ketoprofen—Gastrointestinal pain—Niacin—atherosclerosis	0.000162	0.00183	CcSEcCtD
Ketoprofen—Nausea—Rosuvastatin—atherosclerosis	0.000161	0.00182	CcSEcCtD
Ketoprofen—CYP2C9—cardiovascular system—atherosclerosis	0.000161	0.0183	CbGeAlD
Ketoprofen—SLCO1A2—liver—atherosclerosis	0.000161	0.0182	CbGeAlD
Ketoprofen—Feeling abnormal—Pravastatin—atherosclerosis	0.00016	0.00181	CcSEcCtD
Ketoprofen—ALB—liver—atherosclerosis	0.00016	0.0181	CbGeAlD
Ketoprofen—Pruritus—Ezetimibe—atherosclerosis	0.00016	0.0018	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000159	0.0018	CcSEcCtD
Ketoprofen—Hypersensitivity—Simvastatin—atherosclerosis	0.000159	0.00179	CcSEcCtD
Ketoprofen—Diarrhoea—Lovastatin—atherosclerosis	0.000158	0.00178	CcSEcCtD
Ketoprofen—Urticaria—Niacin—atherosclerosis	0.000157	0.00177	CcSEcCtD
Ketoprofen—Abdominal pain—Niacin—atherosclerosis	0.000156	0.00176	CcSEcCtD
Ketoprofen—Nepafenac—PTGS2—atherosclerosis	0.000155	0.0655	CrCbGaD
Ketoprofen—ABCC4—liver—atherosclerosis	0.000155	0.0175	CbGeAlD
Ketoprofen—Urticaria—Pravastatin—atherosclerosis	0.000155	0.00175	CcSEcCtD
Ketoprofen—Asthenia—Simvastatin—atherosclerosis	0.000155	0.00174	CcSEcCtD
Ketoprofen—Diarrhoea—Ezetimibe—atherosclerosis	0.000155	0.00174	CcSEcCtD
Ketoprofen—Abdominal pain—Pravastatin—atherosclerosis	0.000154	0.00174	CcSEcCtD
Ketoprofen—Pruritus—Simvastatin—atherosclerosis	0.000152	0.00172	CcSEcCtD
Ketoprofen—Dizziness—Lovastatin—atherosclerosis	0.000152	0.00172	CcSEcCtD
Ketoprofen—Magnesium salicylate—PTGS2—atherosclerosis	0.000151	0.064	CrCbGaD
Ketoprofen—Dizziness—Ezetimibe—atherosclerosis	0.000149	0.00169	CcSEcCtD
Ketoprofen—Fenbufen—PTGS2—atherosclerosis	0.000148	0.0627	CrCbGaD
Ketoprofen—Diarrhoea—Simvastatin—atherosclerosis	0.000147	0.00166	CcSEcCtD
Ketoprofen—PTGS1—cardiovascular system—atherosclerosis	0.000147	0.0167	CbGeAlD
Ketoprofen—Vomiting—Lovastatin—atherosclerosis	0.000146	0.00165	CcSEcCtD
Ketoprofen—Hypersensitivity—Niacin—atherosclerosis	0.000146	0.00164	CcSEcCtD
Ketoprofen—Rash—Lovastatin—atherosclerosis	0.000145	0.00164	CcSEcCtD
Ketoprofen—Dermatitis—Lovastatin—atherosclerosis	0.000145	0.00164	CcSEcCtD
Ketoprofen—Headache—Lovastatin—atherosclerosis	0.000144	0.00163	CcSEcCtD
Ketoprofen—Vomiting—Ezetimibe—atherosclerosis	0.000144	0.00162	CcSEcCtD
Ketoprofen—Hypersensitivity—Pravastatin—atherosclerosis	0.000143	0.00162	CcSEcCtD
Ketoprofen—Dizziness—Simvastatin—atherosclerosis	0.000142	0.00161	CcSEcCtD
Ketoprofen—Rash—Ezetimibe—atherosclerosis	0.000142	0.00161	CcSEcCtD
Ketoprofen—Dermatitis—Ezetimibe—atherosclerosis	0.000142	0.00161	CcSEcCtD
Ketoprofen—Asthenia—Niacin—atherosclerosis	0.000142	0.0016	CcSEcCtD
Ketoprofen—Headache—Ezetimibe—atherosclerosis	0.000141	0.0016	CcSEcCtD
Ketoprofen—PTGS2—cardiovascular system—atherosclerosis	0.000141	0.016	CbGeAlD
Ketoprofen—Pruritus—Niacin—atherosclerosis	0.00014	0.00158	CcSEcCtD
Ketoprofen—Asthenia—Pravastatin—atherosclerosis	0.00014	0.00158	CcSEcCtD
Ketoprofen—Pruritus—Pravastatin—atherosclerosis	0.000138	0.00156	CcSEcCtD
Ketoprofen—Vomiting—Simvastatin—atherosclerosis	0.000137	0.00155	CcSEcCtD
Ketoprofen—Nausea—Lovastatin—atherosclerosis	0.000137	0.00154	CcSEcCtD
Ketoprofen—Rash—Simvastatin—atherosclerosis	0.000136	0.00153	CcSEcCtD
Ketoprofen—Dermatitis—Simvastatin—atherosclerosis	0.000136	0.00153	CcSEcCtD
Ketoprofen—Diarrhoea—Niacin—atherosclerosis	0.000135	0.00153	CcSEcCtD
Ketoprofen—Headache—Simvastatin—atherosclerosis	0.000135	0.00152	CcSEcCtD
Ketoprofen—Magnesium salicylate—ALB—atherosclerosis	0.000135	0.0571	CrCbGaD
Ketoprofen—Nausea—Ezetimibe—atherosclerosis	0.000134	0.00151	CcSEcCtD
Ketoprofen—Diarrhoea—Pravastatin—atherosclerosis	0.000133	0.0015	CcSEcCtD
Ketoprofen—Dizziness—Niacin—atherosclerosis	0.000131	0.00148	CcSEcCtD
Ketoprofen—PTGS1—adipose tissue—atherosclerosis	0.00013	0.0147	CbGeAlD
Ketoprofen—Dizziness—Pravastatin—atherosclerosis	0.000129	0.00145	CcSEcCtD
Ketoprofen—Salsalate—PTGS2—atherosclerosis	0.000129	0.0545	CrCbGaD
Ketoprofen—Nausea—Simvastatin—atherosclerosis	0.000128	0.00144	CcSEcCtD
Ketoprofen—Vomiting—Niacin—atherosclerosis	0.000126	0.00142	CcSEcCtD
Ketoprofen—Rash—Niacin—atherosclerosis	0.000125	0.00141	CcSEcCtD
Ketoprofen—Dermatitis—Niacin—atherosclerosis	0.000125	0.00141	CcSEcCtD
Ketoprofen—PTGS2—adipose tissue—atherosclerosis	0.000124	0.0141	CbGeAlD
Ketoprofen—Headache—Niacin—atherosclerosis	0.000124	0.0014	CcSEcCtD
Ketoprofen—Vomiting—Pravastatin—atherosclerosis	0.000124	0.0014	CcSEcCtD
Ketoprofen—Suprofen—PTGS2—atherosclerosis	0.000123	0.0522	CrCbGaD
Ketoprofen—Rash—Pravastatin—atherosclerosis	0.000123	0.00139	CcSEcCtD
Ketoprofen—Dermatitis—Pravastatin—atherosclerosis	0.000123	0.00138	CcSEcCtD
Ketoprofen—Headache—Pravastatin—atherosclerosis	0.000122	0.00138	CcSEcCtD
Ketoprofen—Nausea—Niacin—atherosclerosis	0.000117	0.00133	CcSEcCtD
Ketoprofen—Nausea—Pravastatin—atherosclerosis	0.000116	0.00131	CcSEcCtD
Ketoprofen—CYP2C8—liver—atherosclerosis	0.000112	0.0127	CbGeAlD
Ketoprofen—Fenoprofen—PTGS2—atherosclerosis	0.000106	0.045	CrCbGaD
Ketoprofen—CYP2C9—liver—atherosclerosis	9.98e-05	0.0113	CbGeAlD
Ketoprofen—Mefenamic acid—PTGS2—atherosclerosis	9.87e-05	0.0417	CrCbGaD
Ketoprofen—Naproxen—PTGS2—atherosclerosis	9.69e-05	0.041	CrCbGaD
Ketoprofen—Fenoprofen—ALB—atherosclerosis	9.48e-05	0.0401	CrCbGaD
Ketoprofen—PTGS2—liver—atherosclerosis	8.71e-05	0.00986	CbGeAlD
Ketoprofen—Naproxen—ALB—atherosclerosis	8.63e-05	0.0365	CrCbGaD
Ketoprofen—Phenprocoumon—ALB—atherosclerosis	8.17e-05	0.0346	CrCbGaD
Ketoprofen—Warfarin—ALB—atherosclerosis	7.25e-05	0.0307	CrCbGaD
Ketoprofen—Flurbiprofen—PTGS2—atherosclerosis	6.94e-05	0.0294	CrCbGaD
Ketoprofen—Flurbiprofen—ALB—atherosclerosis	6.19e-05	0.0262	CrCbGaD
Ketoprofen—PTGS2—Metabolism—APOC3—atherosclerosis	6.46e-06	7.31e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—BGN—atherosclerosis	6.44e-06	7.3e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.44e-06	7.29e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—LDLR—atherosclerosis	6.42e-06	7.27e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—BGN—atherosclerosis	6.41e-06	7.26e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—GPX1—atherosclerosis	6.4e-06	7.25e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	6.4e-06	7.25e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—APOA5—atherosclerosis	6.38e-06	7.23e-05	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	6.37e-06	7.22e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ABCA1—atherosclerosis	6.36e-06	7.21e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	6.36e-06	7.21e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—LEP—atherosclerosis	6.34e-06	7.18e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—APOE—atherosclerosis	6.34e-06	7.18e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—APOA5—atherosclerosis	6.34e-06	7.18e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CAV1—atherosclerosis	6.28e-06	7.12e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—APOA1—atherosclerosis	6.27e-06	7.1e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CETP—atherosclerosis	6.27e-06	7.1e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—F2—atherosclerosis	6.25e-06	7.08e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CD36—atherosclerosis	6.24e-06	7.06e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	6.2e-06	7.02e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—NOS2—atherosclerosis	6.18e-06	7e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	6.17e-06	6.99e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	6.16e-06	6.98e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	6.15e-06	6.97e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	6.14e-06	6.95e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PLA2G1B—atherosclerosis	6.11e-06	6.92e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	6.07e-06	6.88e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—ESR1—atherosclerosis	6.06e-06	6.86e-05	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	6.05e-06	6.85e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	6.04e-06	6.84e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	6.02e-06	6.81e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—SCARB1—atherosclerosis	6e-06	6.8e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	6e-06	6.8e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CYP27A1—atherosclerosis	5.99e-06	6.78e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PIK3CG—atherosclerosis	5.98e-06	6.78e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—F2—atherosclerosis	5.98e-06	6.77e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	5.98e-06	6.77e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	5.97e-06	6.76e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ALOX5—atherosclerosis	5.93e-06	6.72e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—MTHFR—atherosclerosis	5.91e-06	6.69e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ALOX5—atherosclerosis	5.9e-06	6.68e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	5.89e-06	6.68e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.84e-06	6.62e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PPARA—atherosclerosis	5.8e-06	6.57e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	5.75e-06	6.51e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PIK3CG—atherosclerosis	5.72e-06	6.48e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—APOA2—atherosclerosis	5.68e-06	6.43e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	5.68e-06	6.43e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ALOX15—atherosclerosis	5.68e-06	6.43e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	5.68e-06	6.43e-05	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	5.67e-06	6.43e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—HMGCR—atherosclerosis	5.67e-06	6.42e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—AGT—atherosclerosis	5.62e-06	6.36e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ABCG5—atherosclerosis	5.61e-06	6.35e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	5.6e-06	6.34e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—APOE—atherosclerosis	5.5e-06	6.23e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—MAPK3—atherosclerosis	5.48e-06	6.21e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.48e-06	6.21e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—IGF1—atherosclerosis	5.48e-06	6.21e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—HMOX1—atherosclerosis	5.46e-06	6.18e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CAV1—atherosclerosis	5.45e-06	6.17e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.45e-06	6.17e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—APOA1—atherosclerosis	5.44e-06	6.16e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—INS—atherosclerosis	5.42e-06	6.14e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—LPA—atherosclerosis	5.42e-06	6.13e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CCL2—atherosclerosis	5.33e-06	6.04e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—NAMPT—atherosclerosis	5.32e-06	6.02e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—NAMPT—atherosclerosis	5.29e-06	5.99e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.29e-06	5.99e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—LIPC—atherosclerosis	5.29e-06	5.99e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.26e-06	5.96e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—LIPC—atherosclerosis	5.26e-06	5.95e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—APOC3—atherosclerosis	5.25e-06	5.95e-05	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—IL6—atherosclerosis	5.25e-06	5.94e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—BGN—atherosclerosis	5.24e-06	5.94e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IGF1—atherosclerosis	5.24e-06	5.94e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—APOB—atherosclerosis	5.23e-06	5.92e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—APOC3—atherosclerosis	5.22e-06	5.92e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—LDLR—atherosclerosis	5.22e-06	5.91e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	5.21e-06	5.9e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—SERPINE1—atherosclerosis	5.2e-06	5.89e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—APOA5—atherosclerosis	5.19e-06	5.88e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—LDLR—atherosclerosis	5.19e-06	5.88e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CETP—atherosclerosis	5.1e-06	5.78e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GSTM1—atherosclerosis	5.09e-06	5.76e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CETP—atherosclerosis	5.07e-06	5.74e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ABCA1—atherosclerosis	5.05e-06	5.72e-05	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—AKT1—atherosclerosis	5.05e-06	5.72e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	5.04e-06	5.71e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	5e-06	5.66e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—LPL—atherosclerosis	4.99e-06	5.66e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—SERPINE1—atherosclerosis	4.98e-06	5.64e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—NOS3—atherosclerosis	4.97e-06	5.63e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PIK3CG—atherosclerosis	4.97e-06	5.62e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—APOB—atherosclerosis	4.96e-06	5.61e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	4.94e-06	5.6e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	4.9e-06	5.54e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	4.88e-06	5.53e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—SCARB1—atherosclerosis	4.88e-06	5.53e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GPX1—atherosclerosis	4.87e-06	5.52e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—SCARB1—atherosclerosis	4.86e-06	5.5e-05	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—AKT1—atherosclerosis	4.84e-06	5.48e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ALOX5—atherosclerosis	4.83e-06	5.47e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PPARG—atherosclerosis	4.79e-06	5.43e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.75e-06	5.39e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NOS3—atherosclerosis	4.75e-06	5.38e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CD36—atherosclerosis	4.74e-06	5.37e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—LPL—atherosclerosis	4.73e-06	5.36e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—INS—atherosclerosis	4.7e-06	5.32e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—HMGCR—atherosclerosis	4.61e-06	5.22e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PRKCG—atherosclerosis	4.6e-06	5.21e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—HMGCR—atherosclerosis	4.59e-06	5.19e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—MTHFR—atherosclerosis	4.5e-06	5.09e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.46e-06	5.05e-05	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	4.43e-06	5.02e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PPARA—atherosclerosis	4.41e-06	5e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—HMOX1—atherosclerosis	4.33e-06	4.91e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—NAMPT—atherosclerosis	4.33e-06	4.9e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—ALB—atherosclerosis	4.31e-06	4.88e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4.3e-06	4.87e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—LIPC—atherosclerosis	4.3e-06	4.87e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—APOC3—atherosclerosis	4.28e-06	4.84e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—AGT—atherosclerosis	4.27e-06	4.84e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MTHFR—atherosclerosis	4.26e-06	4.83e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—LDLR—atherosclerosis	4.25e-06	4.81e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—APOE—atherosclerosis	4.19e-06	4.74e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.16e-06	4.71e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—APOB—atherosclerosis	4.15e-06	4.7e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CETP—atherosclerosis	4.15e-06	4.7e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PDGFB—atherosclerosis	4.15e-06	4.7e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CAV1—atherosclerosis	4.15e-06	4.7e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—APOA1—atherosclerosis	4.14e-06	4.69e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.14e-06	4.68e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—NOS3—atherosclerosis	4.12e-06	4.67e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ABCA1—atherosclerosis	4.11e-06	4.66e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ABCA1—atherosclerosis	4.09e-06	4.63e-05	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—AKT1—atherosclerosis	4.07e-06	4.61e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GSTM1—atherosclerosis	4.04e-06	4.57e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—IL6—atherosclerosis	4.01e-06	4.54e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SCARB1—atherosclerosis	3.97e-06	4.5e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—APOE—atherosclerosis	3.97e-06	4.49e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—LPL—atherosclerosis	3.96e-06	4.49e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CAV1—atherosclerosis	3.93e-06	4.45e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—APOA1—atherosclerosis	3.92e-06	4.44e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.87e-06	4.38e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GPX1—atherosclerosis	3.87e-06	4.38e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MMP9—atherosclerosis	3.81e-06	4.32e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PIK3CG—atherosclerosis	3.78e-06	4.28e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NFKB1—atherosclerosis	3.77e-06	4.27e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PTGS2—atherosclerosis	3.77e-06	4.27e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CD36—atherosclerosis	3.77e-06	4.27e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—HMGCR—atherosclerosis	3.75e-06	4.25e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MAPK8—atherosclerosis	3.71e-06	4.2e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—AKT1—atherosclerosis	3.7e-06	4.19e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NOS2—atherosclerosis	3.7e-06	4.19e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PPARG—atherosclerosis	3.65e-06	4.13e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—VEGFA—atherosclerosis	3.58e-06	4.05e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—INS—atherosclerosis	3.58e-06	4.05e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—MTHFR—atherosclerosis	3.57e-06	4.04e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—HMOX1—atherosclerosis	3.53e-06	3.99e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—HMOX1—atherosclerosis	3.51e-06	3.97e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PPARA—atherosclerosis	3.5e-06	3.97e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—VEGFA—atherosclerosis	3.42e-06	3.88e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—AGT—atherosclerosis	3.39e-06	3.84e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—STAT3—atherosclerosis	3.39e-06	3.84e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—INS—atherosclerosis	3.39e-06	3.84e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.39e-06	3.83e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—MAPK3—atherosclerosis	3.39e-06	3.83e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—APOB—atherosclerosis	3.38e-06	3.83e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—APOB—atherosclerosis	3.36e-06	3.8e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ABCA1—atherosclerosis	3.35e-06	3.79e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—APOE—atherosclerosis	3.32e-06	3.76e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CAV1—atherosclerosis	3.29e-06	3.73e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GSTM1—atherosclerosis	3.29e-06	3.72e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—APOA1—atherosclerosis	3.28e-06	3.72e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TGFB1—atherosclerosis	3.28e-06	3.72e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ALB—atherosclerosis	3.28e-06	3.71e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GSTM1—atherosclerosis	3.27e-06	3.7e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MAPK3—atherosclerosis	3.24e-06	3.67e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—LPL—atherosclerosis	3.23e-06	3.65e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—LPL—atherosclerosis	3.21e-06	3.63e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GPX1—atherosclerosis	3.15e-06	3.56e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TGFB1—atherosclerosis	3.14e-06	3.56e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—NOS3—atherosclerosis	3.14e-06	3.55e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GPX1—atherosclerosis	3.13e-06	3.54e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—SERPINE1—atherosclerosis	3.11e-06	3.53e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CD36—atherosclerosis	3.06e-06	3.47e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CD36—atherosclerosis	3.05e-06	3.45e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PIK3CG—atherosclerosis	3e-06	3.4e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NOS3—atherosclerosis	2.97e-06	3.37e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—MTHFR—atherosclerosis	2.9e-06	3.29e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PPARG—atherosclerosis	2.89e-06	3.28e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—MTHFR—atherosclerosis	2.89e-06	3.27e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—HMOX1—atherosclerosis	2.87e-06	3.25e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PTGS2—atherosclerosis	2.87e-06	3.25e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PPARA—atherosclerosis	2.85e-06	3.23e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—INS—atherosclerosis	2.84e-06	3.22e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PPARA—atherosclerosis	2.83e-06	3.21e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—AGT—atherosclerosis	2.76e-06	3.13e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—APOB—atherosclerosis	2.75e-06	3.11e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—AGT—atherosclerosis	2.74e-06	3.11e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—APOE—atherosclerosis	2.7e-06	3.06e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—APOE—atherosclerosis	2.69e-06	3.04e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CAV1—atherosclerosis	2.68e-06	3.03e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GSTM1—atherosclerosis	2.67e-06	3.03e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—APOA1—atherosclerosis	2.67e-06	3.03e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CAV1—atherosclerosis	2.66e-06	3.02e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—APOA1—atherosclerosis	2.66e-06	3.01e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—LPL—atherosclerosis	2.63e-06	2.97e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ALB—atherosclerosis	2.6e-06	2.95e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GPX1—atherosclerosis	2.56e-06	2.9e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CD36—atherosclerosis	2.49e-06	2.83e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—NOS3—atherosclerosis	2.49e-06	2.82e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PIK3CG—atherosclerosis	2.44e-06	2.76e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PIK3CG—atherosclerosis	2.43e-06	2.75e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IL6—atherosclerosis	2.37e-06	2.68e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—MTHFR—atherosclerosis	2.36e-06	2.68e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PPARG—atherosclerosis	2.36e-06	2.67e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PPARG—atherosclerosis	2.34e-06	2.65e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PPARA—atherosclerosis	2.32e-06	2.63e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—INS—atherosclerosis	2.31e-06	2.62e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—INS—atherosclerosis	2.3e-06	2.6e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—AKT1—atherosclerosis	2.28e-06	2.59e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—AGT—atherosclerosis	2.25e-06	2.54e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—APOE—atherosclerosis	2.2e-06	2.49e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—AKT1—atherosclerosis	2.18e-06	2.47e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CAV1—atherosclerosis	2.18e-06	2.47e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—APOA1—atherosclerosis	2.18e-06	2.46e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—STAT3—atherosclerosis	2.12e-06	2.4e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ALB—atherosclerosis	2.12e-06	2.4e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MAPK3—atherosclerosis	2.03e-06	2.29e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—NOS3—atherosclerosis	2.03e-06	2.29e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—NOS3—atherosclerosis	2.01e-06	2.28e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PIK3CG—atherosclerosis	1.99e-06	2.25e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TGFB1—atherosclerosis	1.97e-06	2.23e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PPARG—atherosclerosis	1.92e-06	2.17e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—AKT1—atherosclerosis	1.89e-06	2.15e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—INS—atherosclerosis	1.88e-06	2.13e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PTGS2—atherosclerosis	1.85e-06	2.1e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PTGS2—atherosclerosis	1.84e-06	2.09e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ALB—atherosclerosis	1.72e-06	1.95e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—NOS3—atherosclerosis	1.65e-06	1.87e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PTGS2—atherosclerosis	1.51e-06	1.71e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—IL6—atherosclerosis	1.48e-06	1.68e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—AKT1—atherosclerosis	1.44e-06	1.63e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—AKT1—atherosclerosis	1.37e-06	1.55e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—AKT1—atherosclerosis	1.14e-06	1.3e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—AKT1—atherosclerosis	9.31e-07	1.05e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—AKT1—atherosclerosis	9.26e-07	1.05e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—AKT1—atherosclerosis	7.58e-07	8.58e-06	CbGpPWpGaD
